Investors angry about insulin woes sue Novo Nordisk in Denmark for $1.75B
admin 16th August 2019 Uncategorised 0A group of investors sued Novo Nordisk in Denmark for allegedly misleading the public about its insulin franchise’s downward spiral. The lawsuit claims $1.75 billion in losses as pricing pressures and falling sales sent share prices downward—and as Novo points out, broadly resembles a shareholder suit filed in the U.S.
More: Investors angry about insulin woes sue Novo Nordisk in Denmark for .75B
Source: fierce